SC
COCP icon

Steven Cohen’s Cocrystal Pharma COCP Stock Holding History

Steven Cohen’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-83,333
Closed -$1.36M – 992
2020
Q4 		$1.36M Sell
83,333
-154,762
-65% -$2.15M 0.01% 779
2020
Q3 		$2.66M Buy
+238,095
New +$4.34M 0.01% 666

Other funds holding COCP

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steven Cohen's COCP Position: Q1 2021 in Review

Steven Cohen sold out of Cocrystal Pharma (COCP) in Q1 2021, closing a stake of 83,333 shares — an estimated $1.36M sold.

Steven Cohen first reported a position in COCP in Q3 2020 and held it in 2 quarters. The position peaked at $2.66M in Q3 2020. 35 funds tracked by Wall St. Rank hold COCP as of Q1 2021.

  • Steven Cohen reported no remaining Cocrystal Pharma position as of Q1 2021 after selling out during the quarter.
  • Steven Cohen sold 83,333 Cocrystal Pharma shares in Q1 2021, an estimated $1.36M.
  • Steven Cohen first reported a position in Cocrystal Pharma in Q3 2020 and held it in 2 quarters.
  • Steven Cohen's Cocrystal Pharma position peaked at $2.66M in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2021.

Based on Point72 Asset Management's 13F filing for Q1 2021, filed 17 May 2021.